Genetic predisposition for muscle strength linked to longer lifespan and lower disease risk

A study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, showed that a genetic predisposition for higher muscle strength predicts a longer lifespan and a lower risk for developing common diseases.

EMA validates application of Genmab-Pfizer cancer therapy

Share this article Genmab-Pfizer’s cervical cancer treatment is under EMA review. Credit: Jo Panuwat D / Shutterstock.com. The European Medicines Agency (EMA) has validated the

February 5, 2024

Renaissance to in-license St Jude’s humanised antibody

Hu14.18 is in development for the treatment of newly diagnosed high-risk neuroblastoma. Credit: Kateryna Kon/Shutterstock.com. Renaissance Pharma has signed an agreement to in-license St Jude

August 1, 2023

Doctors Sue California Over Implicit Bias Training

Two California doctors and a nonprofit filed a lawsuit against top officials of the Medical Board of California (MBC) Tuesday to block a state requirement

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.